Core Viewpoint - Mengniu Dairy (2319.HK) anticipates a slight decrease in operating profit margin for 2025, projected at 7.9%-8.1%, compared to 8.2% in 2024, but still shows improvement over years prior to 2024 [1] Financial Performance - The company expects profit attributable to shareholders for 2025 to be approximately 1.4 billion to 1.6 billion yuan, a significant increase from 104.5 million yuan in the same period of 2024 [1] - The anticipated impairment provision for 2025 is estimated to be around 2.2 billion to 2.4 billion yuan, related to idle production facilities and certain financial and contractual assets with uncertain repayment capabilities [1] Market Trends - With the stabilization of raw milk prices and improving demand, liquid milk revenue is expected to show steady recovery in the second half of 2025 [1] - Categories such as fresh milk, milk powder, and cheese are projected to achieve double-digit growth throughout the year, indicating a diversified business development trend [1] Cash Flow and Operations - The anticipated impairment provision or loss is not expected to have a significant adverse impact on the company's current and future operations or cash flow [1] - The company expects stable year-on-year performance in operating cash flow for the previous year [1]

Core Viewpoint - Despite facing challenges from changing consumer demand, channel scenarios, and competitive environments, the company maintains its "one body, two wings" strategy, focusing on R&D innovation, brand leadership, channel upgrades, and digital transformation to enhance core competitiveness and operational efficiency [2] Financial Performance - The company expects a stable operating profit margin of 7.9% to 8.1% for the fiscal year 2025, with robust year-on-year performance in operating cash flow [2] - A provision for impairment of approximately RMB 2.2 billion to 2.4 billion is anticipated for certain idle production facilities, accounts receivable, and entrusted loans, which is considered a non-recurring loss and does not affect the company's current or future core business operations [2][3] - The expected net profit attributable to shareholders for 2025 is projected to be around RMB 1.4 billion to 1.6 billion [3] Strategic Adjustments - The impairment adjustment is a proactive measure to identify credit risks and optimize resource allocation during the industry's downturn, ensuring that financial statements accurately reflect asset values in preparation for an upcoming industry recovery [3] - The decision to recognize impairments is based on independent and professional judgment, focusing on specific historical risks, and is part of a risk management strategy to prevent future issues [3] Industry Outlook - The Chinese dairy industry is at a critical turning point, with raw milk prices stabilizing after a significant decline, which is expected to benefit leading companies like the company as the market pricing order improves [4] - Analysts predict a cyclical recovery in the industry by 2026, which will favor leading dairy companies due to reduced low-price competition and enhanced market share through product innovation and brand strength [4][5] Product Performance - The company reports strong growth across various product categories, with liquid milk revenue showing steady recovery and double-digit growth in fresh milk, milk powder, and cheese segments [5] - The flagship brand "TeLunSu" maintains a leading position in the premium market, and the company’s ice cream business saw a 15% year-on-year increase in revenue [5] Marketing and Sales Strategy - The company is leveraging a combination of "Winter Olympics marketing + Lunar New Year scenarios + refined operations" to drive sales, resulting in a strong start to 2026 [6] - International investment banks have given positive evaluations, with Citigroup raising the target price to HKD 21.10, and Goldman Sachs expecting significant sales growth in January due to the late timing of the Lunar New Year [6][7] Future Expectations - The company is expected to benefit from a stable raw milk price and operational leverage, leading to a faster growth in net profit as it enters a new profit expansion phase [7] - The recent one-time adjustment in "book profits" is aimed at ensuring sustainable growth in "real profits" in the future, reflecting improved governance, asset quality, and strategic focus [7]

Group 1 - The company anticipates a 7% to 8% year-on-year decline in total revenue for 2025 due to ongoing changes in consumer demand, channel scenarios, and competitive environment [1] - Operating profit margin is expected to decrease slightly to between 7.9% and 8.1% for 2025, down from 8.2% in 2024, although it is still projected to be higher than in years prior to 2024 [1] - The company plans to make impairment provisions of approximately RMB 2.2 billion to RMB 2.4 billion for certain idle production facilities and financial assets with uncertain repayment capabilities [1] Group 2 - The company is committed to its "one body, two wings" development strategy, focusing on solidifying brand foundations and market share while enhancing core competitiveness through innovative product offerings [2] - There has been a stabilization in raw milk prices and a continuous improvement in demand, leading to a steady recovery in liquid milk revenue since the second half of 2025 [2] - The company has achieved double-digit growth in categories such as fresh milk, milk powder, and cheese, indicating a trend towards diversified business structure [2]

Group 1 - The company anticipates a 7% to 8% year-on-year decline in total revenue for 2025 due to ongoing changes in consumer demand, channel scenarios, and competitive environment [1] - Operating profit margin is expected to decrease slightly to between 7.9% and 8.1% for 2025, down from 8.2% in 2024, although it is still projected to be higher than in years prior to 2024 [1] - The company plans to make impairment provisions of approximately RMB 2.2 billion to RMB 2.4 billion for certain idle production facilities and financial assets with uncertain repayment capabilities [1] Group 2 - The company is committed to its "one body, two wings" development strategy, focusing on solidifying brand foundations and market share while enhancing core competitiveness through innovative product layouts [2] - There has been a steady recovery in liquid milk revenue since the second half of 2025, with double-digit growth observed in categories such as fresh milk, milk powder, and cheese [2] - The business structure is showing a trend of diversification, with continuous improvement in demand and stabilization of raw milk prices [2]

Group 1 - The core viewpoint of the article is that Mengniu Dairy expects its profit attributable to shareholders to be approximately RMB 1.4 billion to 1.6 billion by 2025 [1] Group 2 - The projected profit range indicates a positive outlook for the company's financial performance in the coming years [1]

CHINA MENGNIU DAIRY COMPANY LIMITED 中國蒙牛乳業有限公司* （在開曼群島註冊成立之有限公司） （股份代號：2319） 有關截至二零二五年十二月三十一日止年度全年净利潤的業務最新資料 本公告乃由中國蒙牛乳業有限公司（「本公司」，連同其附屬公司統稱「本集團」）之董事會 （「董事會」）根據香港聯合交易所有限公司證券上市規則（「上市規則」）第 13.09 條及香港 法例第 571 章證券及期貨條例第 XIVA 部項下內幕消息條文（定義見上市規則）之規定而作出。 根據本集團管理層目前掌握的資料，本公司謹此知會本公司股東（「股東」）及有意投資者： 經計及上述因素，預期本集團截至二零二五年十二月三十一日止年度將錄得本公司擁有人應佔利 潤將約為人民幣 14億元至 16億元 (二零二四年: 人民幣 1.045億元 (經商譽及無形資產相關減值))。 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或 完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產生或因倚賴該 等內容而引致的任何損失承擔任何責任。 本公司始終堅定推進「一體兩翼」發展戰略 ...

Group 1 - The Hong Kong stock market saw a rise in several dairy stocks, with Mengniu Dairy (02319.HK) increasing by 6.29% to HKD 16.06 [1] - China Feihe (06186.HK) experienced a 3.76% increase, reaching HKD 3.86 [1] - Ausnutria Dairy (02425.HK) rose by 3.11%, trading at HKD 2.32 [1] - H&H International Holdings (01112.HK) saw a 1.51% increase, priced at HKD 14.11 [1]

Group 1 - Dairy stocks have seen an increase, with Mengniu Dairy rising by 6.29% to HKD 16.06, China Feihe up by 3.76% to HKD 3.86, Ausnutria increasing by 3.11% to HKD 2.32, and H&H International Holdings gaining 1.51% to HKD 14.11 [1] - The Chinese government has allocated nearly CNY 100 billion in childcare subsidies for this year, aiming to optimize application and review processes for these funds [1] - The government plans to implement pilot programs for childcare service subsidies and develop inclusive childcare services, with an addition of 150,000 inclusive childcare spots nationwide [1]

| 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 02319 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 6,000,000,000 | HKD | | 0.1 HKD | | 600,000,000 | | 增加 / 減少 (-) | | | | | | HKD | | | | 本月底結存 | | | 6,000,000,000 | HKD | | 0.1 HKD | | 600,000,000 | 本月底法定/註冊股本總額： HKD 600,000,000 第 1 頁 共 10 頁 v 1.2.0 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2026年2月28日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 中國蒙牛乳業有限公司 呈交日期: ...

Summary of China Mengniu Dairy Conference Call Company Overview - **Company**: China Mengniu Dairy - **Industry**: Dairy Products - **Market Position**: Second-largest dairy producer in China, following Inner Mongolia Yili - **Key Shareholders**: COFCO (13.5%) and DANONE (7.5%) [10][26] Key Points and Arguments Industry and Market Dynamics - **Liquid Milk Sales Recovery**: After two years of pressure, liquid milk sales are showing early signs of stabilization in 2026, with January sales estimated to have mid- to high-single-digit year-over-year (YoY) growth, a significant improvement from the high-single-digit decline in the second half of 2025 [2][4] - **Raw Milk Price Stabilization**: Following herd destocking, raw milk prices have stabilized around Rmb3/kg, with expectations of a price recovery in 2026 due to continued herd contraction [3][4] - **Impact of Subsidies**: Last year's delivery subsidies boosted demand for freshly prepared milk beverages, cannibalizing packaged liquid milk sales. As these subsidies phase out, Mengniu is expected to regain some market share [3] Financial Performance and Forecasts - **Sales Growth Forecast**: Projected sales growth of 4.6% in 2026, primarily driven by the recovery in liquid milk [4] - **Operating Profit Growth**: Expected operating profit to grow by 10.6% YoY, with an improvement in operating profit margin (OPM) by 40 basis points [4] - **Net Profit Projection**: Anticipated net profit of Rmb5.1 billion, reflecting a 32.8% YoY growth, supported by operational improvements and reduced impairment losses related to raw milk prices [4] Valuation and Investment Recommendation - **Valuation Metrics**: Mengniu's valuation is attractive with an estimated P/E of 11.8x for 2026 and a projected 20% EPS CAGR from 2025 to 2027 [5] - **Target Price**: Reiterated Buy rating with a target price of HK$20.5, implying a 15x P/E for 2026 [5][6] - **Market Capitalization**: Approximately HK$66.9 billion (US$8.57 billion) with a free float of 75% [6] Risks and Challenges - **Economic Sensitivity**: Risks include significant economic slowdown, competition, cost inflation, price resistance, changes in government policies, and regulatory challenges [12] - **Industry Vulnerability**: The dairy industry is sensitive to external risks, including disease outbreaks and regulatory changes that could hinder growth [12] Additional Insights - **Herd Contraction**: The milkable cow herd has been contracting since February 2024, with a 9% reduction from peak levels by the end of 2025 [3] - **Market Trends**: The overall dairy value chain is expected to experience reduced competitive intensity as raw milk prices stabilize [2][3] This summary encapsulates the critical insights from the conference call regarding China Mengniu Dairy's market position, financial outlook, and the broader industry context.